INTRAGLY-F LIFE CAPS
MRP: 2,500
Packaging: 30 Caps
Pack Type: life-caps
Composition:
Glycopyrronium 25mcg + Formoterol Fumarate 6mcg
Indication:
A Fast-acting treatment options for patients with Moderate to severe COPD
Description:
Glycopyrronium 25 mcg + Formoterol Fumarate 6 mcg** is a dual bronchodilator inhalation therapy used for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). This fixed-dose combination includes:
Glycopyrronium – a long-acting muscarinic antagonist (LAMA) that relaxes airway muscles and prevents bronchospasm.
Formoterol Fumarate – a long-acting beta-agonist (LABA) that dilates the bronchi and improves airflow.
Together, they provide enhanced and sustained bronchodilation, reducing symptoms like dyspnea (shortness of breath), cough, and chronic airflow obstruction. This formulation is not intended for use in acute asthma attacks.
Tags:
- Dual-action bronchodilation from LAMA + LABA
- Improves lung function and exercise tolerance
- Reduces COPD exacerbations and hospital visits
- Decreases symptoms like wheezing, coughing, dyspnea
- Enhances overall quality of life for COPD patients
Usage Information
Dosage
Recommended dose: One inhalation twice daily Administer via dry powder inhaler (DPI) or metered-dose inhaler (MDI) as prescribed Do not exceed recommended dosage Rinse mouth after use to avoid irritation Always follow your physician’s guidance for correct inhalation technique and frequency.
Side Effects
Common: Dry mouth Headache Cough Sore throat Muscle cramps Nausea Serious (Rare): Irregular heartbeat Increased blood pressure Paradoxical bronchospasm Urinary retention
Contraindications
Hypersensitivity to glycopyrronium, formoterol, or any component Patients with asthma without ICS therapy Severe cardiac disorders (e.g., arrhythmias) Narrow-angle glaucoma Urinary tract obstruction or retention